Taurine and Cellular Energy: Its Role in Mitochondrial Function and Calcium Regulation

Every cell in the human body requires energy to maintain its structure, perform specialized functions, and respond to changing physiological demands. Whether a skeletal muscle fibre is contracting, a neuron is transmitting information, or a cardiac muscle cell is maintaining its rhythmic activity, these processes depend on a continuous supply of adenosine triphosphate (ATP), the major energy currency of the cell.

Mitochondria play a central role in meeting these energetic demands. Often described as the powerhouses of the cell, mitochondria are responsible for generating much of the ATP required for cellular function through a process called oxidative phosphorylation. However, mitochondrial performance depends on more than the availability of nutrients and oxygen. It also requires the coordinated activity of numerous proteins, enzymes, and regulatory systems that maintain the cellular environment necessary for efficient energy production. For a broader look at these organelles, see our guide to mastering mitochondrial health.

One molecule increasingly discussed in this context is taurine (2-aminoethanesulfonic acid), a naturally occurring sulfur-containing compound found in particularly high concentrations in metabolically active tissues, including skeletal muscle, the heart, and the brain [1]. Although taurine is frequently grouped with amino acids, it is not incorporated into proteins and is therefore considered nonproteinogenic. Rather, it performs several specialized physiological functions, including roles in osmoregulation, membrane stability, cellular stress responses, and calcium homeostasis.

In today’s article, we will look at taurine's relationship with mitochondrial function and intracellular calcium regulation, two processes that are intimately connected to cellular energy metabolism.

Taurine: More Than a Conventional Amino Acid

Taurine differs structurally from the amino acids used to make proteins. It can be synthesized endogenously (within the body) from sulfur-containing amino acids, principally cysteine, although the capacity for synthesis varies between tissues and across species. Taurine is also obtained through the diet, particularly from animal products such as seafood and meat, with smaller amounts generally found in dairy products.

Unlike many amino acids, taurine exists predominantly in its free form within cells. Its relatively high intracellular concentrations suggest that it contributes to fundamental aspects of cellular physiology rather than serving primarily as a substrate or fuel for energy production.

Indeed, taurine is not conventionally regarded as a metabolic fuel. Rather, its contribution to cellular energetics appears to arise through its influence on the machinery responsible for generating and regulating energy.

This distinction is important: a molecule does not need to supply calories or participate directly in ATP synthesis to influence cellular energy availability. It may instead support the efficiency, stability, or regulation of the systems upon which ATP production depends. Research has identified several mechanisms through which taurine may contribute to these processes, particularly within mitochondria [1,2].

Taurine and Mitochondrial Energy Production

To understand taurine's contribution to cellular energy metabolism, it’s useful to consider how mitochondria generate ATP.

During oxidative phosphorylation, electrons derived from nutrient metabolism pass through a series of protein complexes embedded within the inner mitochondrial membrane. Collectively known as the electron transport chain, these complexes establish an electrochemical gradient that drives ATP synthesis. The efficiency of this process depends on the appropriate synthesis, assembly, and functioning of mitochondrial proteins. You can explore this final stage in more detail in our article on ATP synthase.

Interestingly, one of taurine's most clearly established mitochondrial roles involves a process that occurs before these proteins can perform their functions: the modification of mitochondrial transfer RNA (tRNA).

Taurine and Mitochondrial Protein Synthesis

Mitochondria possess their own genetic material, which encodes a small but essential collection of proteins involved in oxidative phosphorylation.

For these proteins to be synthesized correctly, mitochondrial genetic information must be translated into amino acid sequences. This process requires tRNA molecules, which help match the genetic code to the amino acids incorporated into newly synthesized proteins.

Certain mitochondrial tRNAs undergo specialized chemical modifications involving taurine. These modifications occur at the wobble position of particular tRNAs and help ensure accurate recognition of genetic codons during mitochondrial translation [3,5].

Two important examples are the taurine-containing modifications found in mitochondrial tRNAs responsible for decoding leucine and tryptophan codons.

When these modifications are disrupted, mitochondrial protein synthesis may become impaired, potentially compromising the production of components required for oxidative phosphorylation [3,5].

The physiological importance of these modifications is illustrated by mitochondrial disorders such as MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes), in which certain mitochondrial DNA mutations interfere with normal tRNA modification and translation [3,4]. This provides a compelling mechanistic connection between taurine and cellular energy metabolism.

Rather than directly stimulating ATP production, taurine contributes to the molecular processes that enable mitochondria to produce essential respiratory-chain proteins.

Implications for Mitochondrial Efficiency

Experimental research has also associated taurine depletion with impaired mitochondrial respiration, altered electron transport chain activity, and increased production of reactive oxygen species (ROS) [5,6].

ROS are natural byproducts of cellular metabolism, and their production is not inherently harmful. At physiological concentrations, they participate in important signalling processes. However, excessive ROS production relative to cellular antioxidant capacity can contribute to oxidative damage and mitochondrial dysfunction.

Taurine's relationship with oxidative stress appears to be largely indirect. Unlike conventional antioxidants that directly neutralize reactive molecules, taurine may help limit conditions that favour excessive ROS production, including disturbances in mitochondrial protein synthesis and electron transport. This distinction matters because taurine should not simply be described as a direct mitochondrial antioxidant. Its influence on oxidative stress is more appropriately understood through its broader contribution to mitochondrial function and cellular homeostasis [2,6].

Calcium Regulation: Connecting Energy Demand and Supply

Mitochondrial energy production does not operate independently of the rest of the cell. It must respond continuously to fluctuations in energy demand. One of the most important signalling molecules coordinating these responses is calcium.

Calcium ions (Ca²⁺) regulate numerous cellular processes, including muscle contraction, neurotransmitter release, enzyme activity, and intracellular signalling. In skeletal and cardiac muscle, calcium is especially important because changes in its intracellular concentration initiate contraction. However, calcium also influences mitochondrial metabolism.

When cellular activity increases, calcium signals can stimulate mitochondrial pathways involved in ATP production, helping match energy supply to the demands imposed by cellular work [7].

This relationship is particularly relevant in tissues with rapidly fluctuating energy requirements. Taurine has been linked to calcium handling in experimental muscle and cardiac models, but the underlying mechanisms and their clinical relevance remain context-dependent [1,8].

Why Skeletal Muscle and the Heart Matter

Skeletal and cardiac muscle provide particularly useful examples of the relationship between taurine, calcium regulation, and cellular energetics.

Both tissues contain substantial quantities of taurine and require highly coordinated interactions between calcium signalling, mitochondrial ATP production, and contractile function.

During skeletal muscle contraction, calcium released from the sarcoplasmic reticulum enables the interaction between actin and myosin. ATP is then required both to support cross-bridge cycling and to restore intracellular calcium concentrations during relaxation.

This means that muscle contraction and recovery depend on two closely related processes: calcium regulation and energy availability.

Experimental studies have shown that taurine depletion can impair skeletal muscle function, while taurine supplementation has demonstrated beneficial effects in certain animal models of muscular dysfunction [8,9]. However, translating these observations into practical recommendations requires a degree of caution. Human skeletal muscle appears to defend its taurine concentration even when oral supplementation substantially increases circulating taurine, and human performance findings remain mixed [14,15].

A physiological requirement for taurine does not necessarily mean that additional taurine improves muscle performance in individuals with adequate taurine status.

Similarly, evidence that taurine supports mitochondrial function under conditions of depletion or disease does not establish that supplementation increases mitochondrial ATP production in healthy individuals.

The same distinction applies to cardiac muscle, where taurine's importance for normal physiology is supported by experimental and clinical observations, but the effects of supplementation depend on the population and outcomes investigated [1].

Taurine, Aging, and Mitochondrial Health

Interest in taurine has expanded considerably following research exploring its relationship with biological aging [10,11]. To learn more about the broader cellular context, read our overview of epigenetics and aging.

A prominent 2023 study reported that taurine concentrations declined with age in several animal models and that taurine supplementation improved selected measures of health and lifespan in experimental organisms [12].

These findings attracted substantial attention because mitochondrial dysfunction, impaired cellular stress responses, and altered metabolic regulation are commonly discussed features of biological aging.

However, a subsequent study using data from humans, nonhuman primates, and mice challenged the idea that declining circulating taurine is a consistent feature or reliable biomarker of aging, highlighting considerable variability between individuals and populations [13]. This later finding does not, by itself, disprove every mechanistic or intervention result from the earlier animal research, but it does weaken the case for circulating taurine as a universal aging marker.

Furthermore, changes in circulating taurine concentrations do not necessarily reflect taurine availability within specific tissues or establish a causal relationship with mitochondrial function.

Although the experimental findings are intriguing, there is currently insufficient evidence to conclude that taurine supplementation slows human aging or reliably improves mitochondrial function in otherwise healthy adults.

Understanding the difference between mechanistic plausibility and demonstrated clinical benefit is essential when interpreting this emerging research.

What Does This Mean for Taurine Supplementation?

Taurine is available through the diet and as a nutritional supplement. Its physiological importance is well established, particularly in tissues with substantial metabolic and contractile demands. However, the evidence supporting taurine's normal biological functions is considerably stronger than the evidence that increasing taurine intake beyond adequate levels enhances cellular energy production.

Several questions remain unresolved. For example, it is unclear whether supplementation meaningfully alters mitochondrial taurine availability in healthy individuals, whether any such changes improve oxidative phosphorylation, or which populations might benefit most from additional intake.

Furthermore, findings from isolated cells, animal models, and clinical populations with specific disorders cannot automatically be generalized to healthy humans.

Future research examining mitochondrial function, calcium handling, tissue taurine concentrations, and clinically meaningful physiological outcomes will be important in clarifying the potential applications of taurine supplementation.

Conclusion

Taurine occupies an interesting position in cellular energy metabolism. Although it does not function as a conventional energy substrate, it contributes to processes that support the machinery responsible for ATP production.

Its involvement in mitochondrial tRNA modification provides a particularly compelling molecular explanation for its importance in mitochondrial protein synthesis and respiratory-chain function. At the same time, its potential influence on intracellular calcium homeostasis connects taurine to the signalling systems that coordinate cellular activity with energy demand. Together, these mechanisms help explain why taurine is abundant in metabolically active tissues such as skeletal muscle and the heart.

The emerging science suggests that taurine is more than a passive cellular constituent. Nevertheless, establishing its physiological importance is not equivalent to demonstrating that supplementation improves mitochondrial function, physical performance, or longevity in healthy humans. For now, taurine is best understood as a contributor to the maintenance and regulation of cellular energetics, rather than a direct stimulant of energy production.

 

References

1. Schaffer SW, Jong CJ, Ramila KC, Azuma J. Physiological roles of taurine in heart and muscle. J Biomed Sci. 2010;17(Suppl 1):S2. doi:10.1186/1423-0127-17-S1-S2.
2. Jong CJ, Azuma J, Schaffer S. Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids. 2012;42(6):2223-2232. doi:10.1007/s00726-011-0962-7.
3. Tomizawa K, Wei FY. Posttranscriptional modifications in mitochondrial tRNA and its implication in mitochondrial translation and disease. J Biochem. 2020;168(5):435-444. doi:10.1093/jb/mvaa098.
4. Kirino Y, Goto Y, Campos Y, Arenas J, Suzuki T. Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease. Proc Natl Acad Sci U S A. 2005;102(20):7127-7132. doi:10.1073/pnas.0500563102.
5. Asano K, Suzuki T, Saito A, et al. Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease. Nucleic Acids Res. 2018;46(4):1565-1583. doi:10.1093/nar/gky068.
6. Jong CJ, Sandal P, Schaffer SW. The role of taurine in mitochondria health: more than just an antioxidant. Molecules. 2021;26(16):4913. doi:10.3390/molecules26164913.
7. Glancy B, Balaban RS. Role of mitochondrial Ca²⁺ in the regulation of cellular energetics. Biochemistry. 2012;51(14):2959-2973. doi:10.1021/bi2018909.
8. De Luca A, Pierno S, Camerino DC. Taurine: the appeal of a safe amino acid for skeletal muscle disorders. J Transl Med. 2015;13:243. doi:10.1186/s12967-015-0610-1.
9. Warskulat U, Flögel U, Jacoby C, et al. Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J. 2004;18(3):577-579. doi:10.1096/fj.03-0496fje.
10. Martínez de Toda I, Vida C, Garrido A, de la Fuente M. Redox parameters as markers of the rate of aging and predictors of life span. J Gerontol A Biol Sci Med Sci. 2020;75(4):613-620. doi:10.1093/gerona/glz033.
11. Chen Z, Niu Z. Taurine and glutamine supplementation in aging: systemic mechanisms, exercise interactions, and modulation of muscular and neurobiological pathways. Front Physiol. 2026;17:1809107. doi:10.3389/fphys.2026.1809107.
12. Singh P, Gollapalli K, Mangiola S, et al. Taurine deficiency as a driver of aging. Science. 2023;380(6649):eabn9257. doi:10.1126/science.abn9257.
13. Fernandez ME, Bernier M, Price NL, et al. Is taurine an aging biomarker? Science. 2025;388(6751):eadl2116. doi:10.1126/science.adl2116.
14. Spriet LL, Whitfield J. Taurine and skeletal muscle function. Curr Opin Clin Nutr Metab Care. 2015;18(1):96-101. doi:10.1097/MCO.0000000000000135.
15. Kurtz JA, VanDusseldorp TA, Doyle JA, Otis JS. Taurine in sports and exercise. J Int Soc Sports Nutr. 2021;18(1):39. doi:10.1186/s12970-021-00438-0.